Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Boehringer Ingelheim
Argus Health
AstraZeneca
Medtronic
Fuji
Deloitte
Chubb
QuintilesIMS

Generated: April 21, 2018

DrugPatentWatch Database Preview

BROMODIPHENHYDRAMINE HYDROCHLORIDE AND CODEINE PHOSPHATE Drug Profile

« Back to Dashboard

When do Bromodiphenhydramine Hydrochloride And Codeine Phosphate patents expire, and what generic alternatives are available?

Bromodiphenhydramine Hydrochloride And Codeine Phosphate is a drug marketed by Wockhardt and is included in one NDA.

The generic ingredient in BROMODIPHENHYDRAMINE HYDROCHLORIDE AND CODEINE PHOSPHATE is bromodiphenhydramine hydrochloride; codeine phosphate. There are two drug master file entries for this compound. Additional details are available on the bromodiphenhydramine hydrochloride; codeine phosphate profile page.
Summary for BROMODIPHENHYDRAMINE HYDROCHLORIDE AND CODEINE PHOSPHATE
Drug patent expirations by year for BROMODIPHENHYDRAMINE HYDROCHLORIDE AND CODEINE PHOSPHATE

US Patents and Regulatory Information for BROMODIPHENHYDRAMINE HYDROCHLORIDE AND CODEINE PHOSPHATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wockhardt BROMODIPHENHYDRAMINE HYDROCHLORIDE AND CODEINE PHOSPHATE bromodiphenhydramine hydrochloride; codeine phosphate SYRUP;ORAL 088626-001 Oct 12, 1984 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Cipla
Fuji
Chinese Patent Office
Accenture
Express Scripts
Julphar
Moodys
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.